Spinal Muscular Atrophy Treatment Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Type 1, Type 2, Type 3, Type 4), By Treatment (Gene Therapy, Drug), By Route of Administration, By Region, And Segment Forecasts

Market Segmentation

• Spinal Muscular Atrophy Treatment Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Type 1
  • Type 2
  • Type 3
  • Type 4
• Spinal Muscular Atrophy Treatment Treatment Outlook (Revenue, USD Billion, 2018 - 2030)
  • Gene Therapy
  • Drug
    • Spinraza
    • Zolgensma (AVXS-101)
    • Evrysdi
    • Others
• Spinal Muscular Atrophy Treatment Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
  • Oral
  • Injection
• Spinal Muscular Atrophy Treatment Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • North America Spinal Muscular Atrophy Treatment Market, by Type 
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • North America Spinal Muscular Atrophy Treatment Market, by Treatment
      • Gene Therapy
      • Drug
        • Spinraza
        • Zolgensma (AVXS-101)
        • Evrysdi
        • Others
    • North America Spinal Muscular Atrophy Treatment Market, by Route of Administration
      • Oral
      • Injection
    • U.S.
      • U.S. Spinal Muscular Atrophy Treatment Market, by Type
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • U.S. Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • U.S. Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Canada
      • Canada Spinal Muscular Atrophy Treatment Market, by Type
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Canada Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Canada Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Mexico
      • Mexico Spinal Muscular Atrophy Treatment Market, by Type
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Mexico Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Mexico Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
  • Europe
    • Europe Spinal Muscular Atrophy Treatment Market, by Type
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Europe Spinal Muscular Atrophy Treatment Market, by Treatment
      • Gene Therapy
      • Drug
        • Spinraza
        • Zolgensma (AVXS-101)
        • Evrysdi
        • Others
    • Europe Spinal Muscular Atrophy Treatment Market, by Route of Administration
      • Oral
      • Injection
    • UK
      • UK Spinal Muscular Atrophy Treatment Market, by Type
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • UK Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • UK Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Germany
      • Germany Spinal Muscular Atrophy Treatment Market, by Type
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Germany Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Germany Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • France
      • France Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • France Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • France Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Italy
      • Italy Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Italy Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Italy Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Spain
      • Spain Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Spain Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Spain Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Norway
      • Norway Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Norway Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Norway Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Denmark
      • Denmark Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Denmark Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Denmark Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Sweden
      • Sweden Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Sweden Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Sweden Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
  • Asia Pacific
    • Asia Pacific Spinal Muscular Atrophy Treatment Market, by Type 
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Asia Pacific Spinal Muscular Atrophy Treatment Market, by Treatment
      • Gene Therapy
      • Drug
        • Spinraza
        • Zolgensma (AVXS-101)
        • Evrysdi
        • Others
    • Asia Pacific Spinal Muscular Atrophy Treatment Market, by Route of Administration
      • Oral
      • Injection
    • Japan
      • Japan Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Japan Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Japan Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • China
      • China Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • China Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • China Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • India
      • India Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • India Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • India Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • South Korea
      • South Korea Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • South Korea Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • South Korea Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Australia
      • Australia Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Australia Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Australia Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Thailand
      • Thailand Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Thailand Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Thailand Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
  • Latin America
    • Latin America Spinal Muscular Atrophy Treatment Market, by Type 
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Latin America Spinal Muscular Atrophy Treatment Market, by Treatment
      • Gene Therapy
      • Drug
        • Spinraza
        • Zolgensma (AVXS-101)
        • Evrysdi
        • Others
    • Latin America Spinal Muscular Atrophy Treatment Market, by Route of Administration
      • Oral
      • Injection
    • Brazil
      • Brazil Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Brazil Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Brazil Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Argentina
      • Argentina Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Argentina Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Argentina Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
  • Middle East & Africa
    • Middle East & Africa Spinal Muscular Atrophy Treatment Market, by Type 
      • Type 1
      • Type 2
      • Type 3
      • Type 4
    • Middle East & Africa Spinal Muscular Atrophy Treatment Market, by Treatment
      • Gene Therapy
      • Drug
        • Spinraza
        • Zolgensma (AVXS-101)
        • Evrysdi
        • Others
    • Middle East & Africa Spinal Muscular Atrophy Treatment Market, by Route of Administration
      • Oral
      • Injection
    • South Africa
      • South Africa Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • South Africa Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • South Africa Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Saudi Arabia
      • Saudi Arabia Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Saudi Arabia Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Saudi Arabia Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • UAE
      • UAE Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • UAE Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • UAE Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection
    • Kuwait
      • Kuwait Spinal Muscular Atrophy Treatment Market, by Type 
        • Type 1
        • Type 2
        • Type 3
        • Type 4
      • Kuwait Spinal Muscular Atrophy Treatment Market, by Treatment
        • Gene Therapy
        • Drug
          • Spinraza
          • Zolgensma (AVXS-101)
          • Evrysdi
          • Others
      • Kuwait Spinal Muscular Atrophy Treatment Market, by Route of Administration
        • Oral
        • Injection

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance